title: MK-801 (dizocilpine): synergist and conditioned stimulus in bromocriptine-induced psychomotor sensitization.
abstract: Intraperitoneal injections of the D2/D3 dopamine agonist bromocriptine (5.0 mg/kg, IP) induced locomotion that became progressively stronger on successive days of testing. The sensitized response developed twice as rapidly when the non-competitive NMDA antagonist MK-801 (0.25 mg/kg, IP) was given 30 min after bromocriptine (so that the peak effects of the two drugs overlapped). In a second group of animals, MK-801 was given 30 min prior to bromocriptine (the pretreatment regimen typical of studies where MK-801 is reported to block cocaine, amphetamine or morphine sensitization) and locomotion was monitored during the pretreatment period; in this case sensitization to the locomotor-stimulating effects of MK-801 alone (in the pretreatment period) as well as sensitization to the locomotor-stimulating effects of the drug combination (following the second injection) were observed. No sensitization to the effects of MK-801 alone (pretreatment) were seen in animals that received saline rather than bromocriptine as their second injection in this experiment. Thus MK-801 does not block but rather enhances bromocriptine sensitization; it appears to do so by a synergism with the locomotor effects of bromocriptine and by becoming a conditioned stimulus for the sensitized response. These findings confirm the earlier report that NMDA receptor activation is not critical to bromocriptine-induced sensitization, and they illustrate the importance of controls for conditioning and state-dependency phenomena in studies of drug interactions in psychomotor sensitization.
authors.affiliation: Center for Studies in Behavioral Neurobiology, Concordia University, Montreal, Quebec, Canada.
authors.forename: R A
authors.initials: RA
authors.lastname: Wise
authors.forename: A
authors.initials: A
authors.lastname: Mendrek
authors.forename: W A
authors.initials: WA
authors.lastname: Carlezon
mesh_terms: D000818:Animals; D001971:Bromocriptine / Q000494:pharmacology*; D003213:Conditioning, Psychological / Q000187:drug effects*; D016291:Dizocilpine Maleate / Q000494:pharmacology*; D004357:Drug Synergism; D008124:Locomotion / Q000187:drug effects*; D008297:Male; D051381:Rats; D013997:Time Factors
chemical_list: D001971:Bromocriptine; D016291:Dizocilpine Maleate